Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

InterCure Ltd. (INCR)

NGM · Drug Manufacturers - Specialty & Generic

$0.92-0.00 (-0.05%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$54.5M
P/E (TTM)
EPS
$-0.22
Div Yield
52W Range
$0.68–$1.77
Beta
0.57

Company overview

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

InterCure Ltd. has not issued a press release in this window.

SEC filings

All filings →

InterCure Ltd. has not filed an SEC document in this window.

InterCure Ltd. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
76,805 sh-64.2%
105,944 sh-2.7%
97,273 sh0.0%
66,253 sh+418.6%
71,600 sh+12.4%
22,990 sh-4.8%
22,539 sh0.0%
11,882 sh-6.0%

People at InterCure Ltd.

All people →

No officers or directors have been indexed for InterCure Ltd..

Quarterly financials

Full financials →
Revenue trend
12/24
NI
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.